ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

IOVA Iovance Biotherapeutics Inc

10.85
-0.115 (-1.05%)
2024年5月14日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Iovance Biotherapeutics Inc IOVA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.115 -1.05% 10.85 08:56:18
始値 安値 高値 終値 前日終値
11.21 10.42 11.47 10.88 10.965
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1006:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1005:06EDGAR2Form 8-K - Current report
2024/5/1005:01GLOBEIovance Biotherapeutics Reports First Quarter 2024 Financial..
2024/5/0119:01GLOBEIovance Biotherapeutics to Host First Quarter 2024 Financial..
2024/4/3019:01GLOBEIovance Biotherapeutics to Present at Upcoming Conferences
2024/4/2505:01GLOBEIovance Biotherapeutics to Present Clinical and..
2024/4/2006:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
2024/3/2306:30GLOBEIovance Biotherapeutics Reports Inducement Grants under..
2024/3/0708:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0422:00EDGAR2Form 8-K - Current report
2024/3/0420:30GLOBEIovance Biotherapeutics Announces FDA has Lifted Clinical..
2024/3/0207:00GLOBEIovance Biotherapeutics to Present at Upcoming Conferences
2024/2/2921:30EDGAR2Form 8-K - Current report
2024/2/2906:05EDGAR2Form 8-K - Current report
2024/2/2906:01GLOBEIovance Biotherapeutics Reports Fourth Quarter and Full Year..
2024/2/2306:53EDGAR2Form 8-K - Current report
2024/2/2222:45GLOBEIovance Biotherapeutics to Host Fourth Quarter and Full-Year..
2024/2/2206:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2107:23EDGAR2Form 8-K - Current report
2024/2/2106:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2020:30GLOBEIovance Biotherapeutics, Inc. Announces Pricing of $211..
2024/2/2020:03EDGAR2Form 8-K - Current report
2024/2/1707:30GLOBEIovance Biotherapeutics Reports Inducement Grants under..
2024/2/1705:38GLOBEIovance Biotherapeutics to Host Conference Call and Webcast..
2024/2/1705:19GLOBEIovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA..
2024/2/1420:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2007:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
2024/1/1908:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1908:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1908:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0907:03EDGAR2Form 8-K - Current report
2023/12/2821:27IHMARKETNEWSWall Street Highlights: Amazon to Introduce Ads on Prime..
2023/12/2807:00EDGAR2Form 8-K - Current report
2023/12/2721:54DJNIovance Shares Fall Premarket As FDA Places Study On Hold..
2023/12/2721:00GLOBEIovance Biotherapeutics Announces Clinical Program Update..
2023/12/2307:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
2023/11/1807:00GLOBEIovance Biotherapeutics Reports Inducement Grants under..
2023/11/0807:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0806:05EDGAR2Form 8-K - Current report
2023/11/0806:01GLOBEIovance Biotherapeutics Reports Third Quarter and..
2023/11/0105:01GLOBEIovance Biotherapeutics to Host Third Quarter and..
2023/10/3122:05GLOBEIovance Biotherapeutics to Present Clinical and Pre-Clinical..
2023/10/2106:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
2023/10/1909:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock